Capital International, Inc./CA/
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 895213
Los Angeles, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$81,665,889
+$9,450,101 QoQ
Shares Held
164,407
+1.7% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#125
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $249,590,047 across 7 Biotechnology names. VRTX ranks #2 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
305,477 | $87,051,780 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
164,407 | $81,665,889 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,074,948 | $60,272,334 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,154 | $8,202,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,671 | $7,727,741 | |
| 6 | ASND |
Ascendis Pharma A/S
|
10,443 | $2,785,356 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
34,560 | $1,884,902 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,665,889 | 164,407 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $72,215,788 | 161,723 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $72,383,457 | 159,660 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $74,936,789 | 191,341 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $78,013,731 | 175,233 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $63,620,504 | 131,225 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $49,988,761 | 124,134 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $51,322,973 | 110,353 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $49,769,627 | 106,182 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $41,184,435 | 98,525 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $31,754,916 | 78,043 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,539,363 | 61,941 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,843,852 | 56,389 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,167,373 | 38,618 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,809,324 | 37,431 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,395,207 | 42,810 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,747,906 | 59,434 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $15,672,814 | 60,056 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $23,535,190 | 107,173 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,978,285 | 93,601 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,247,737 | 115,299 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,914,991 | 115,943 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $51,400,641 | 217,486 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $58,761,864 | 215,941 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $59,269,979 | 204,161 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $38,456,051 | 161,614 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||